Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-22-010816
Filing Date
2022-04-27
Accepted
2022-04-27 16:46:07
Documents
4
Period of Report
2022-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A cdxcproxystatement2022def1.htm DEF 14A 648912
2 a03n0jd_chromadexxcommon001.jpg GRAPHIC 176693
3 a03n0jd_chromadexxcommon002.jpg GRAPHIC 138018
4 image.jpg GRAPHIC 5296
  Complete submission text file 0001628280-22-010816.txt   1091047
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
ChromaDex Corp. (Filer) CIK: 0001386570 (see all company filings)

EIN.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37752 | Film No.: 22860499
SIC: 2833 Medicinal Chemicals & Botanical Products